Page 51 - SaxoCell Annual Report22/23
P. 51

Concrete  processes  for  integrating  SaxoCellOMICS  into  selected  projects  such  as  ECP-CAR,
             UltraCAR-T, MSC-PreStiGe and CAR-NK4.0 were also developed. Contacts were made with eight
             SaxoCell  projects  to  discuss  project  plans  and  identify  needs.  In  addition,  successful  pilot
             experiments with single cell technologies were conducted in collaboration with a local research
             group.  The  data  management  plan  developed  in  SaxoCellOMICS  governs  the  GDPR-compliant
             collection, storage and handling of data.

             Another important aspect is the collaboration with the NFDI consortium GHGA (German Human
             Genome Phenome Archive). SaxoCellOMICS will benefit from the GHGA infrastructure and serve as
             a  bridge  to  manage  project  data  according  to  GHGA  guidelines.  In  addition,  SaxoCellOMICS  has
             offered courses to train scientists in (single cell) transcriptomics. Moerover, a Galaxy Server has
             been set up to allow scientists to analyze their transcriptome sequencing data.



              SaxoCell-  CLINICS     Assays     Processing    Inter-   Validation  Transfer
               projects                                     pretation


                                                                                                     New
                           Sample Ma-               Data ma-       Machine              Efficacy   industry
                           nagement       Genomics  nagement       Learning   Clin.                 partner
                                          .Single cell         Data           studies   .Targets
                           Bio bank       .FACS     .......integration  ...Bioinf.  Fit-for-  ...Biomarker  New
                                                                   Systems    purpose                projects
                           Clinical       Histo     Quality        bio                  Patient     Better
                           metadata                 control                             stratifi.  therapies


             Presentation of the technologies and competences bundled in SaxoCellOMICS as well as their interaction with SaxoCell
             projects in order to accompany the development and production of gene and cell therapeutics and to create new fields of
             action for industry and science.

             Overall, SaxoCellOMICS has made significant progress by identifying a broad range of methods and
             technologies,  developing  SOPs,  coordinating  collaboration  among  partners,  and  promoting
             integration into specific projects.
                                                                                                              46
   46   47   48   49   50   51   52   53   54   55   56